Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

4 terminated/withdrawn out of 48 trials

Success Rate

87.1%

+0.6% vs industry average

Late-Stage Pipeline

15%

7 trials in Phase 3/4

Results Transparency

0%

0 of 27 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
24(64.9%)
Phase 3
4(10.8%)
Phase 2
3(8.1%)
Phase 4
3(8.1%)
Phase 1
2(5.4%)
Early Phase 1
1(2.7%)
37Total
N/A(24)
Phase 3(4)
Phase 2(3)
Phase 4(3)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (48)

Showing 20 of 48 trials
NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT03308305Completed

Cracking Coma: Towards EEG and MRI Based Precision Medicine After Cardiac Arrest

Role: collaborator

NCT05116254Phase 1Terminated

Sarcomas and DDR-Inhibition; a Combined Modality Study

Role: collaborator

NCT04294927Not ApplicableRecruiting

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

Role: lead

NCT01315015Not ApplicableCompleted

Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial

Role: collaborator

NCT03705403Phase 2Terminated

IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study

Role: collaborator

NCT06772714Enrolling By Invitation

10-year Follow-up of the Ponto Wide-implant

Role: lead

NCT02321228Not ApplicableActive Not Recruiting

Early Salpingectomy (Tubectomy) With Delayed Oophorectomy in BRCA1/2 Gene Mutation Carriers

Role: lead

NCT01957332Not ApplicableActive Not Recruiting

IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer

Role: collaborator

NCT04217421Phase 3Recruiting

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass

Role: collaborator

NCT02555384Not ApplicableWithdrawn

AMblyopia Treatment Through PErceptual Training in Children (AMPEL)

Role: collaborator

NCT03495375Not ApplicableCompleted

Treating Impulsivity in Adults With Probiotics

Role: collaborator

NCT02333175Not ApplicableCompleted

Care for Late Stage Parkinsonism

Role: collaborator

NCT02385188Phase 3Completed

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

Role: lead

NCT02625662Completed

Facioscapulohumeral Dystrophy in Children

Role: lead

NCT03811223Phase 4Unknown

Effects of Evolocumab Versus Placebo Added to Standard Lipid-lowering Therapy on Fasting and Post Fat Load Lipids in Patients With Familial Dysbetalipoproteinemia

Role: collaborator

NCT01856738Phase 4Terminated

Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease

Role: collaborator

NCT03264417Completed

Pulmonary Function Test Study - Automated Interpretation

Role: collaborator

NCT02422888Phase 4Unknown

Reducing Micro Vascular Dysfunction in Acute Myocardial Infarction by Ticagrelor

Role: collaborator

NCT03453944Not ApplicableUnknown

NMES to Prevent Respiratory Muscle Atrophy in Mechanically Ventilated Patients

Role: lead